|
|
Article: Studies Will Assess Prophylactic Potential Of Anti-Inflammatory Drug.(Celebrex may prevent lung cancer)
- Article from:
- Cancer Weekly
- Article date:
- August 21, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 AUG 21 - (NewsRx.com & NewsRx.net) --
Can a common anti-inflammatory drug help prevent lung cancer? Researchers at University of California, Los Angeles, Jonsson Cancer Center are seeking volunteers for two new research studies to find out.
For the first time, the studies will investigate whether the anti-inflammatory drug Celebrex has the potential to prevent lung cancer in people at high risk of developing the disease, which is expected to kill more than 157,000 American men and women this year.
One study involves lung cancer survivors who are at high risk of experiencing a recurrence or developing a new lung cancer. The other study ...